Tianjin’s Jinghai district held this year’s first collective signing ceremony of 19 projects with a total investment of 4.03 billion($594.77 million). The newly introduced enterprises are primarily related to the three industrial fields of biomedicine, new energy, and high-end equipment manufacturing, which are the development priority of the district.

Freeway Intelligent Robot Technology (Shanghai) Co., Ltd. signed an agreement with the Tianjin Health Industry International Cooperation Demonstration Zone, with an investment of 200 million yuan, to build a smart medical and health robot R&D center with Jinghai.

Jinghai has been attracting investment for characteristic industrial chains, with newly introduced high-tech industrial projects accounting for over half of the total, and the actual use of domestic capital for the year hitting 15 billion yuan, said Liu Wenchuang, head of the district’s cooperation office.

In 2022, a number of high-quality enterprises, such as Wuhan Power Battery and Tianshili (Tianjin) New Energy, settled in Jinghai. Domestic capital from outside the city reached 11.05 billion yuan, a year-on-year increase of 9.74 percent.

The district also features a medical cluster with abundant medical resources, including Peking Union Medical College Hospital and the Chinese Medicine University, forming a full-cycle life system that integrates the key links of R&D, application, and education.